{"organizations": [], "uuid": "07e152ac8c1062f4fa439290380a8309b70e79c3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180221.html", "section_title": "Archive News &amp; Video for Wednesday, 21 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-arix-bioscience-and-ipsen-signs-st/brief-arix-bioscience-and-ipsen-signs-strategic-agreement-to-develop-and-commercialise-innovative-therapies-idUSFWN1QB08D", "country": "US", "domain_rank": 408, "title": "BRIEF-Arix Bioscience And Ipsen Signs Strategic Agreement To Develop And Commercialise Innovative Therapies", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.024, "site_type": "news", "published": "2018-02-21T15:25:00.000+02:00", "replies_count": 0, "uuid": "07e152ac8c1062f4fa439290380a8309b70e79c3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-arix-bioscience-and-ipsen-signs-st/brief-arix-bioscience-and-ipsen-signs-strategic-agreement-to-develop-and-commercialise-innovative-therapies-idUSFWN1QB08D", "ord_in_thread": 0, "title": "BRIEF-Arix Bioscience And Ipsen Signs Strategic Agreement To Develop And Commercialise Innovative Therapies", "locations": [], "entities": {"persons": [{"name": "ipsen", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "arix bioscience plc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "arix", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 21 (Reuters) - Arix Bioscience Plc:\n* ARIX BIOSCIENCE AND IPSEN SIGN A STRATEGIC AGREEMENT TO DEVELOP AND COMMERCIALISE INNOVATIVE THERAPIES\n* IPSEN WILL CONTRIBUTE RESEARCH, DEVELOPMENT AND COMMERCIAL EXPERTISE TO PARTNERSHIP\n* ARIX WILL PROVIDE IPSEN WITH ACCESS TO ITS UNIQUE NETWORK OF PROFESSIONAL AND SCIENTIFIC ADVISORS Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-21T15:25:00.000+02:00", "crawled": "2018-02-22T17:44:48.015+02:00", "highlightTitle": ""}